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Constitutive expression of the c-H-ras oncogene inhibits
doxorubicin-induced apoptosis and promotes cell survival in a
rhabdomyosarcoma cell line
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Sinmary Drugs used in anti-cancer chemotherapy are thought to exert their cytotoxic action by induction of
apoptosis. Genes have been identified which can mediate or modulate this drug-induced apoptosis, among
which are c-myc, p53 and bcl-2. Since expression of oncogenic ras genes is a frequent observation in human
cancer, we investigated the effects of the c-H-ras oncogene on anti-cancer drug-induced apoptosis. Apoptosis
induced by a 2 h doxorubicin exposure was measured by in situ nick translation and flow cytometry in a rat
cell line (R2T24) stably transfected with the c-H-ras oncogene and in a control cell line (R2NEO) transfected
only with the antibiotic resistance gene neo. Both cell lines (R2T24 and R2NEO) had nearly identical growth
characteristics, including cell doubling time, distribution over the cell cycle phases and plating efficiency in soft
agar. Doxorubicin exposure of the R2NEO cells led to massive induction of apoptosis. In contrast, R2T24
cells, expressing the c-H-ras oncogene, showed significantly less apoptosis after doxorubicin incubation.
Doxorubicin induced approximately 3- to 5-fold less cytotoxicity in the R2T24 cells than in the R2NEO cells,
as determined by clonogenic assay in soft agar. No difference was observed in intracellular doxorubicin
accumulation between the two cell lines, indicating that the classical, P-glycoprotein-mediated multidrug
resistance phenotype is not involved in the observed differences in drug sensitivity. In conclusion, our data
show that constitutive expression of the c-H-ras oncogene suppresses doxorubicin-induced apoptosis and
promotes cell survival, suggesting that human tumours with ras oncogene expression might be less susceptible
to doxorubicin treatment.
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Chemotherapy failure due to cellular drug resistance is still a
major problem in most cancer patients. A variety of drug
resistance mechanisms have been characterised using in vitro
cell lines made resistant to the different classes of anti-cancer
agents. Qualitative and quantitative alterations in cellular
target proteins, drug metabolism, repair mechanisms and
drug efflux from the cell, among others, can cause drug
resistance in vitro. However, a clear relationship between
these cellular biochemical alterations and chemotherapy
failure in patients could not be estabhshed for most drug
resistance mechanisms identified so far. These resistance
mechanisms have in common that they concern, directly or
indirectly, the interaction of the drug molecule with its intra-
cellular target molecules. A different approach for the
elucidation of the mechanisms of cellular drug resistance is to
study how cells are killed by cytotoxic drugs and to unravel
the events that occur as a consequence of the drug-target
interaction that finally leads to cell death.
It is now well appreciated that most anti-cancer drugs can
exert their cytotoxic action by triggering a conserved, gene-
activated programme for cell death, often referred to as
apoptosis (Wyllie et al., 1980; Dive and Hickman, 1991;
Eastman and Barry, 1992; Sen and D'Incalci, 1992; Wyllie,
1993). Apoptosis is the normal physiological method of cell
death during, for example, embryogenesis and tissue homeos-
tasis, and can also be induced by a large variety of external
stimuli, such as viral infections and toxic insults. Therefore, it
may well be that the susceptibility of a cancer cell to drug-
induced apoptosis is an important determinant in the thera-
peutic response (Dive and Hickman, 1991). Recent evidence
strongly suggests that modulation of the apoptotic cell res-
ponse can lead to drug resistance. It has been shown that the
bcl-2 gene can prevent or markedly reduce cell kill induced
by anti-cancer drugs (Reed, 1994). This oncogene is a
member of a superfamily of related genes, including bax
(Oltvai et al., 1993) and bcl-x (Boise et al., 1993), which
normally regulate apoptosis in mammalian cells and are
thought to induce cytotoxic drug resistance by blocking a
final common pathway to apoptotic cell death. Although the
molecular mechanism of apoptosis is yet unknown, several
other (onco)genes have been shown to mediate or modulate
the apoptotic pathway, among which are the tumour-
suppressor gene p53 and the proto-oncogene c-myc. In some
cell systems, overexpression of these genes induces or
facilitates apoptosis (Yonish-Rouach et al., 1991; Evan et al.,
1992; Shaw et al., 1992). It is very likely that other
(onco)genes involved in cell proliferation will also play a role
in the process of apoptosis. Since oncogenic activation of the
ras gene is frequently observed in human cancer (Bos, 1989),
we investigated, in our effort to characterise drug resistance
parameters in human tumours, the effects of the c-H-ras
oncogene on chemotherapy-induced apoptosis.
Materials and nethod
Cell lines
The rhabdomyosarcoma cell line R2 and the transfectants,
R2T24 and R2NEO, have been described previously (Her-
mens and Bentvelzen, 1992), and were maintained in
monolayer culture in Dulbecco's modified culture medium,
supplemented with 10% fetal calf serum, 100 units m.1
penicillin, 100 jgmlm' streptomycin and 2mM L-glutamine.
The cells were cultured at 37'C in a humidified incubator
with 8.5% carbon dioxide. The R2T24 cell line was co-
transfected with the plasmid pT24 carrying the c-H-ras
oncogene (Reddy et al., 1982) and the plasmid pKo carrying
the neo gene (Davies and Gimenez, 1980). The R2NEO cell
line was transfected with the neo gene only. Southern blot
analysis with the 6.6 kb BamHI fragment of the pT24 plas-
mid revealed that the R2T24 cell line contains six copies of
the c-H-ras oncogene per cell (Hermens and Bentvelzen,
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19941992). The R2T24 cells exhibit constitutive expression of the
c-H-ras oncogene, as determined by dot-blot and Northern
blot assay (Hermens and Bentvelzen, 1992).
For induction of apoptosis, the cells were seeded in 75 cm2
flasks and 24h later incubated for 2 h with doxorubicin at
various concentrations, diluted in culture medium without
serum. Thereafter, the cells were washed three times with
phosphate-buffered saline (PBS) (pH 7.4) and furter cul-
tured in drug-free medium for either 24, 48, 72 or 96 h.
Quantification ofapoptosLs by in situ nick translation
Several methods have been described for the detection of
apoptotic cells, based on the various charactristics of the
apoptotic response (Wyllie et al., 1980). The landmark of
apoptosis is endonucleolysis, a process whereby nuclear
DNA is initially degraded at the nucleosomal linker regions
(Arends et al., 1990). Electrophoresis of such degraded DNA
reveals a so-called ladder pattern of nuckosome-sized
fragments of 180 kb, or a multiple of this. The DNA ladder
technique is very often used for the detection of apoptotic
cells. Unfortunately, this assay system is difficult to quanti-
tate and cannot be used to evaluate apoptosis in individual
cells. In the present study, we have used the quantitative in
situ nick translation assay of Gorczyca et al. (1993a, b) for
the detection of DNA breaks, in which the 3'-hydroxyl ter-
mini of DNA breaks are labelled with biotinylated dUTP by
Escherichia coli DNA polymerase. The biotinylated dUTP
molecules incorporated into the DNA can be quantiated by
flow cytometry upon binding to fluoresceinated avidin. At
different time points (24, 48, 72 and 96 h) after drug incuba-
tion, cells were fixed in 1% formaldehyde in PBS (pH 7.4) for
30min on ice. After washing with PBS, the cells were
resuspended in 70% ice-cold ethanol in PBS and stored at
-20-C until further processing. For in situ nick translation
the fixed cells were washed in PBS and resuspended in buffer
containing 5 mM magnesium chloride, 10 mM P-mercapto-
ethanol, 50mM Tris pH 7.8, 1 unitml1 E. coli DNA poly-
merase, 0.2 nmol of biotin-1 1-dUTP and 0.2 nmol of
unlabelled dATP, dCTP and dGTP. After incubation for
90min at 15C, the cells were washed with PBS supp-
lemented with 0.1°/% Triton X-100, and resuspended in stain-
ing buffer consisting of 2.5gLgml-' avidin-fluorescein
isothiocyanate (FITC) in 4 x saline sodium citrate buffer
(1 x SSC = 0.15 M sodium chloride, 0.015 M sodium citrate),
0.1% Triton X-100 and 5% (w/v) non-fat dry milk. Staining
was performed for 30min at 3TC. Thereafter, the cells were
washed with PBS. DNA was counterstained with propidium
iodide (1 zgml-') for 30 min at 4C in PBS. Flow cytometry
was performed on a FACScan flow cytometer (Becton
Dickinson) with excitation at 488 nm. The following
parameters were measured: forward light scatter, perpen-
dicular light scatter, FITC fluorescence (515-545nm) and
fluorescence of the DNA-propidium iodide complex
(563-607nm). Cell debris was excluded from analysis by
appropriate forward light scatter threshold setting.
Cytotoxicity assay
Doxorubicin-induced cytotoxicity was determined by colony
formation in soft agar. Cells were incubated for 2 h with
doxorubicin (concentration range 10 nm to 3.3 M), washed
twice and plated in triplicate at a density of 102, 103, 10' and
I05 cells per 35 mm Petri dish in ml of fresh medium
containing 0.3% soft agar. Colonies were counted after 10
days of incubation at 37C and 8.5% carbon dioxide.
Intracellular doxorubicin accumukation
Intracellular doxorubicin accumulation was measured as de-
scribed previously (Nooter et al., 1983). Cellular anthra-
cyclne net uptake can be quantitated by flow cytometry by
measuring the fluorescence of the anthracycline molecules
upon excitation with laser light of 488 nm (Nooter et al.,
1983, 1989). The fluorescence which is emitted by the cells
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upon excitation by the laser light was registered on a
photomultiplier of the FACScan flow cytometer. Data
analysis was performed using histogram analysis of the
LYSYS II software program (Becton Dickinson). The accu-
mulation of doxorubicin was expressed in arbitrary units
(au.) by calculating the mean fluorescence distribution of
each cell sample. Cells (2 x 10i ml-') in RPMI without
phenol red buffered with 10 mM HEPES buffer (pH 7.4) were
incubated at 3TC and 8.5% carbon dioxide either for 60 min
with doxorubicin (1 gM) or for 60 min with doxorubicin
(1 pM), followed by another incubation for 60min after the
addition ofcyclosporin A (3 FuM). The incubations were stop-
ped by putting the cells on melting ice. After washing twice
with ice-cold PBS (pH 7.4) the cells were stored at 4C until
flow cytometric analysis.
Relts
Growth characteristics ofthe cell lines
Rat rhabdomyosarcoma R2 cells were stably transfected with
plasmids containing the ras oncogene and/or the neo gene,
resulting in the establishment of the cell lines R2T24 and
R2NEO respectively. These cell lines have been described
previously (Hermens and Bentvelzen, 1992), and their
relevant growth characteistics will be sumarised here. The
R2T24 cell line contains six copies of the ras oncogene per
cell, as estimated by Southern blot analysis. Dot-blot and
Northen blot hybridisation showed abundant ras mRNA
expression in R2T24 cells. The in vitro doubling time of the
R2, R2T24 and R2NEO cell lines is 0.9, 1.0, and 1.0 days
respectively. Cell cycle analysis ofcells in logarithmic growth
showed no differences between the R2, R2T24 and R2NEO
cells in the distribution over the cell cycle phases. The mean
proportions of cells in GI, S and G2/M were 50%, 31% and
19% for R2 cells, 54%, 30% and 16% for R2T24 cells and
56%, 28% and 16% for R2NEO cells.
Doxorubicin-inducedapoptosis
A 2 h incubation of exponentially growing R2 or R2NEO
cells with doxorubicin (1 FuM) resulted in an apoptotic res-
ponse, as determined 24h later by cell morphology, DNA
degradation and in situ nick translation assay. The cells had
a typical apoptotic feature with condensed chromatin and
nuclear fragmentation. DNA degradation in nucleosome-
sized fragments could be detected by qualitative gel electro-
phoresis (Sdlins and Cohen, 1987) (data not shown). Prior to
drug incubation, the R2 parental and the R2NEO cell lines
only showed very low levels of spontaneous apoptosis, as
determined by in situ nick translation assay (Figure la).
However, after doxorubicin incubation apoptotic cells could
be distinguished in R2 and R2NEO cultures on the basis of
DNA content and biotin-dUTP labelling In Figure lb-Id,
R2NEO cell cultures are shown at t = 24, t = 48 and t = 72 h
after doxorubicin exposure. Extensive biotin-dUTP labelling
was observed at t = 24 h (Figure lb), which increased with
time. At t =48 h, two distinct apoptotic cell populations
were present, representing about 70% of the total number of
cells analysed. One cluster of apoptotic cells is only shifted
on the vertical axis owing to incorporation of biotin-dUTP
and has a normal DNA content. The other cluster ofapopto-
tic cells has a reduced DNA content, probably as a result of
loss of diffusible DNA of low molcular weight (200-1000
bp; mono- and short oligonuceosomes) (Gorczyca et al.,
1993a). At t = 72 h, the vast majority (about 90%) of cells
were apoptotic, and formed one cluster with predominantly a
subnormal DNA content (Figure ld). In contrast, at t =
24 h, R2T24 cells remained mostly viable after doxorubicin
incubation and showed very little DNA degradation upon gel
electrophoresis (data not shown). In the in situ nick transla-
tion assay a very small fraction (about 7%) of R2T24 cells
was labelled above background (Figure le). Although, in the
ras-transfected cultures the number of apoptotic cells alsoraso.cogene4nuc.d dru r cse
K Nooter et a
558 a
101
101
R2NIO
_ l. 24 h
1ur.4 a -
0 20 4-0 -i0 - 1U
0
O 200 400 mW im 0 400 m m 1000
DNA-pklium io_id. fluorescerce (a.u.)
(DNA_w
I
101
RtO 48-h
10 1- - . '' . e W 0 200 400 m00 mJO lie 01
f
10
R2T24 72 h
o -' 4060 0 m00 1000
Fure 1 Labelling of DNA strand breaks with biotin-dUTP in control, neo-transfected (R2NEO) and c-H-ras-transfected (R2T24)
R2 cells. The extent of DNA strand breaks is esimated by avidin-FITC fluorescence (ordinate) and cellular DNA content by
DNA-propidium iodide fluorescence (abscissa), both expressed in arbitrary units (a.u.). The cells were treated with doxorubicin
(1 luM) for 2 h and at the indicated time points thereafter labelled with biotin-dUTP by in situ nick translation and counterstained
with propidium iodide. Control, untreated R2NEO cells. The position ofcells in GI, S, or G2 + M is indicated. AP, apoptotic cells.
Data from representative experiments.
increased in time (up to about 40% at t = 72 h) (Figure If),
there was a striking difference between the ras-transfected
and the neo-transfected cells (compare Figure Id and f).
Figure 2 shows the time course of drug-induced apoptosis
in R2NEO and R2T24 cells at various doxorubicin concen-
trations. In the R2NEO cells the proportion of apoptotic
cells increased with time at all drug concentrations tested,
and the highest drug concentrations induced the highest
percentages of apoptotic cells. At 1 JM doxorubicin - a
concentration that gives more than 4 log cell kill in a
clonogenic assay on the R2NEO cells (Figure 3) - 96 h after
drug incubation practically all cells were apoptotic (Figure
2d). Compared with the neo-transfected cells, the apoptotic
response in the ras-transfected cultures was clearly delayed
and less extensive. Ninety-six hours after drug incubation
(1 lM) a large population of cells with normal DNA content
and only background biotin-dUTP labelling was still present
in the R2T24 culture, and these surviving cells started to
repopulate the culture flasks. In order to quantitate the
differences in cell survival between R2NEO and R2T24 cells
after doxorubicin incubation, we performed clonogenic
assays.
Doxorubicin-induced cytotoxicity
Doxorubicin-induced cytotoxicity was determined by colony
formation in soft agar. Survival was expressed as percentage
of colony formation in the control cultures, that is without
drug incubation. In the control cultures the plating
efficiencies varied between 80% and 90%, and no differences
were found in this respect between the parental (R2) cells, the
neo-transfected (R2NEO) cells and the c-H-ras-transfected
(R2T24) cells. However, in the presence of doxorubicin the
R2T24 cells were drug resistant by a factor of about 3-5 as
compared with the R2 and R2NEO cells (Figure 3).
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Fwe 2 Timne course of doxorubicin-induced apoptosis in neo-
transfected (R2NEO) (0) and c-H-ras-transfected (R2T24) (U)
R2 cells at various drug concentrations. Apoptosis was assessed
by flow cytometry as described previously (Gorczyca et al.,
1993a, b). The number of apoptotic cells is expressed as percen-
tage of the total number of cells analysed (mean ± standard
deviation of at least two independent experiments). Significant
differences (Wilcoxon's signed-rank test, a = 0.05) in the percen-
tage drug-induced apoptosis between R2NEO and R2T24 cells
are indicated by an asterisk.
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v-ras oncogeneinduced drug resistance
It has been reportled iChin 199Ti that the promoter o
the human mdrl P-glxcoprotein gene can be actix-ated b- th
c-H-raS oncoiene. Since the mcdrl P-glxcoprotein conter
resistance to hydrophobic natural product cxtotoxic drug
ie.g anthracvclines bv acting as a drug extrusion pump tha
activelx loxxers the intracellular drug accumulation (Chin e
a!.. 19934. the..e result. x-ould impl% that in our c-H-raS
transfected R'T'4 cells. up-regulation of the P-glxcoproteir
mi=ht have occurred. To invesstigate that possibilitV.
determined Steadx-state intracellular doxorubicin accumula
tion in R' R2'NEO and R'T24 cell.. bv floxx- cvtometrn
lNooter er ai.. 19xS. l994 This. technique makes use of tht
spontaneou.S. fluore..cence oI the anthrac>-cline molecule,
upon excitation xwith lasser light at 4"S nm In Figure 4 tht
res.ult-S are shhoxn O- cell.s incubated wxith doxorubicin alone
and of c.ll. thLt xwer- incubated xwith doxorubicin plus cclo.
sporin A Cxclo.porin A :;. a competitixe inhibitor ot th
t7bidrl P-glc-oprotein drug pump (Nooter et a!.l.99 an
cauese an incrcase in intracellular anthra.xline accumulatior
xxhen added to P-glc-oprotein-expressing cell.. In that w-ax
cxclosporp n A can b-e used in experiments desianed to demon
S.trate a f^unctional n7cdrl P-glcoprotein drug pump. ThS
intracellular doxorubicin accumulation in R'. R'N-EO an
R'T'4 cell. did not differ stati.ticallv after a 60 min incuba
tion period xvith I um\ doxorubicin (Figure 4. In all three cel
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iRN-EO -2nd :-H-ra--:Tan i:R.:Td R'T' ce11. The .cellS
I' x 1I-t rr.l- ~e vre cben-1:d _: -C. - her :or 6r m;n m: h
d,oxorb:>:n ux N on- or -:o-
-, Irn:n 'WA:h doxorub:-c:n (1 um
--oilox\ed :no:he- :n b&-oi r -or 6"-) m:n oh doxorab1c'n
'lu, S C io..to-:n A uv- Barrs. s:.ndi rd ::ons
lines (R'. R'N-EO and R'T2'4 the addition ot cyclosponin A
lfinal concentration S lM to the incubation medium led to
an increase in intracellular doxorubicin accumulation. prob-
ablv as a result of inhibition of endogenous rat rmdr P-
al-coprotein molecules Deuchars eo al.. 1992h. which in
rodent cell lines often haxve a Somexv-hat elevated basal expres-
sion level. How-ever. also in the presence of cyclosporin A. no
differences xwere found in intracellular doxorubicin accumula-
tion betxveen the control cell lines (R' and R'N-EO) and the
ra>-transfected cell line R2'T'44. Apparently. in the R2 cells
constitutix-e expression of the c-H-raS oncoLene does not
enhance mdr P-Olxcoprotein expre.ssion. Thus. the differences
in drug-induced apoptosis and cell survival between the cont-
rol cell line, and the R'T'4 cell, cannot be ascribed to
differences in intracellular drug accumulation.
Discussion
n In the present study xwe showxed that cells xwith constituti-e
expression of the c-H-raS oncogene wAere approximately S-to
f-fold more resistant to doxorubicin wAhen companng the
drug concentrations needed for identical log cell kill in the
d raS-transfected cells. and in control cells In accordance wAith
these drug resistance data. drug-induced apoptosi-.. as esti-
mated bx the in XIiuu nick translation as..ax. xvas delaved and
ienificantl1 loxwer in the c-H-ra'-transtected cells than in the
control cellS. This inhibition of drug-induced apoptosis bx
constitutix-e c-H-ra' oncogene expression xvas not absolute
but relati-e. since 4 daxvs after a ' h drug exposure wxith 1 piN
doxorubicin exen about 60°o of the c-H-raS-transfected cell.
xvere trigaered into apoptosi-. Hox-ever. in the control neo-
transfected culture. about 100°o ot the cells xvere apoptotic at
that time. In the clonogenic assax. no colonies were scored in
the R'N-EO cultures at 1 imI doxorubicin. while only a S log
cell k-ill wAas found in the R'T'4 cultures at that drug concen-
tration. Apparently. con.stitutive expression of the c-H-raS
oncogene promotes cell survival after cytotoxic drug expo-
..ure bx inhibiting the apoptotic response. Data on the
antiapoptotic effects, of the c-H-ra_ oncogene in line 'Aith the
obs.ervations presented here have also been provided bx
other.. XXWvllie et al. l9_-; Arends eo al. 19934. The first link
betnveen ras and apoptosis came trom a studx b-- Wx-llie er a!
4l9x-. x^-ho showAed that animal tumour. With constitutive
expression of the c-H-rau oncoaene had a remarkably lowA
incidence of spontaneous apoptotic cell death. U.ing an III
lrrLi sx stem in wxhich apoptosis is induced bx serum deprixa-
tion. thex showAed that constitutive expression of the ras.
oncogene reduced apopto..i.. in rat fibrobla..t.. sublected to
..erum xvithdrawAal iArends et al.. 19934.
Several fprotoioncogenes.. including ra_ this. report;
Arends eor a.. 19954. -(Xilliams er al.. 1990. Stras,er et
al 1991. Bissonnette et a!.. 1992: Mivashita and Reed. 1992.
WXang eo al.. 19954.aN (Ex-ans et al.. 19934 and rat /Tropp-
mair et al.. 19924. have been shox-n to inhibit apoptosis in a
xvanetx of experimental model syxstems. Whether these genes
intertere u-ith one and the same apoptotic pathu-ay and how-
thev w-ork is not xet known. The best studied example in this
respect is WLl-. When ox-erexpressed bLl-2 blocks. apoptosis.
including apoptosis induced b- x I ) 2routh factor w-ithdraw-al
(XXilliams ot al.. 19904; (4) ox-erexpression of the wxild-txpe
p53 tumour-suppressor gene XWang er a!. 1993 4543 the
c-mn_c proto-oncogene (Bissonnette er al.. 19924: (44 chemo-
therapeutic agents (NIixashita and Reed. 19924: and 454 lonis-
ing radiation (Strasser eo al.. 1991 4. Different modes of action
have been postulated for the inhibitorx- effects of bcl-' on
induction of apoptosis 4review-ed in Reed. 19944. In a recent
..tudx. the generation of oxx-en free radicals wxas explored
during apoptosis. 4Hockenberx er al.. 199i. bcl-' did not
appear to influence the generation of oxxgen free radicals but
prexvented oxidatix-e damage to cellular constituents. sugge.t-
ino that bcl-' functions in an antioxidant path'-ax to prexent
apoptosis. The current hypothesis on anti-cancer drug-induc-
ed apoptosis is. that the drug-induced DNA damage up-
regulate.. the level o1 xvild-tvpe pI3 protein 4Frit.he tz a
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1993), which in turn, triggers the apoptotic response (Lowe et
al., 1993), and from two studies it can be concluded that
bcl-2 interferes in the apoptotic signal transduction pathway
'downstream' of the events associated with the interactions of
the drug molecules with the intracellular target molecules
(Fisher et al., 1993; Kamesaki et al., 1993). One study partic-
ularly worth mentioning here linked bcl-2 with a member of
the ras superfamily (Fernandez-Sarabia and Bischoff, 1994).
In human cell extracts, the bcl-2 protein has been found to be
associated with the ras-related protein R-ras p23 (Fernandez-
Sarabia and Bischoff, 1994). The authors hypothesised that,
if R-ras were a component of a signal transduction pathway
mediating the induction of apoptosis, the association of R-
ras p23 with bcl-2 could thus lead to suppression of apop-
tosis. However, in the same study, no association was found
between bcl-2 and other members of the ras superfamily,
making a similar scenario for the H-ras oncogene less
likely.
The c-ras p21 proteins participate in the control of cell
proliferation as signal transducers from cell-surface receptors
to the nucleus. The serine/threonine kinase raf-1 probably
acts as an effector of ras function (Kolch et al., 1991; Leevers
et al., 1994; Stokoe et al., 1994), and cells triggered into
apoptosis by growth factor deprivation can be protected by
activated raf(Troppmair et al., 1992). Therefore, an interest-
ing possibility that deserves further study is that the
antiapoptotic effect of the c-H-ras oncogene is mediated by
activated raf-l.
Mutational activation of ras proto-oncogenes is frequently
observed in human tumours (Bos, 1989), and the inhibitory
effect of constitutive ras oncogene expression on drug-
induced apoptosis in vitro could have implications for
tumour cell response to cytotoxic drug treatment in cancer
patients. Our in vitro data showed that in doxorubicin at
1 JiM, a concentration within the clinical range of plasma
concentrations, the neo-transfected cultures did not survive,
whereas a significant proportion of the ras-transfected cells
survived indeed and finally repopulated the cultures. If this
phenomenon also takes place in tumours expressing endo-
genous ras oncogenes, these tumours might be less suscepti-
ble to anti-cancer drug treatment, and it could be anticipated
that such drug-resistant tumour cells contribute to the recur-
rence of tumours.
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